IL1RN has been described as an inhibitor of inflammation [57], and IL1RN gene expression has been reported in advanced stages of cancer that could be related to an evasion of the immune response, a mechanism that some cancers use to continue their progression. The gene discussed is IL1RN; the disease is cancer.